These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 11600882)

  • 21. Late-onset congenital adrenal hyperplasia in a group of hyperandrogenic women.
    Hassíakos DK; Toner JP; Jones GS; Jones HW
    Arch Gynecol Obstet; 1991; 249(4):165-71. PubMed ID: 1665683
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Carrier status for steroid 21-hydroxylase deficiency is only one factor in the variable phenotype of acne.
    Ostlere LS; Rumsby G; Holownia P; Jacobs HS; Rustin MH; Honour JW
    Clin Endocrinol (Oxf); 1998 Feb; 48(2):209-15. PubMed ID: 9579234
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transient hyper-17-hydroxyprogesteronemia: a clinical subgroup of patients diagnosed at neonatal screening for congenital adrenal hyperplasia.
    Cavarzere P; Samara-Boustani D; Flechtner I; Dechaux M; Elie C; Tardy V; Morel Y; Polak M
    Eur J Endocrinol; 2009 Aug; 161(2):285-92. PubMed ID: 19451212
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnosis of late-onset congenital adrenal hyperplasia in clinical practice: current evaluation.
    Sahmay S; Tuten A; Gurleyen H; Oncul M; Benian A; Tamer Erel C
    Minerva Endocrinol; 2014 Sep; 39(3):215-22. PubMed ID: 25068307
    [TBL] [Abstract][Full Text] [Related]  

  • 25. On the origin of the elevated 17-hydroxyprogesterone levels after adrenal stimulation in hyperandrogenism.
    Azziz R; Rafi A; Smith BR; Bradley EL; Zacur HA
    J Clin Endocrinol Metab; 1990 Feb; 70(2):431-6. PubMed ID: 2137133
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Seasonal variation in serum concentrations of reproductive hormones and urinary excretion of 6-sulfatoxymelatonin in men living north and south of the Arctic Circle: a longitudinal study.
    Ruhayel Y; Malm G; Haugen TB; Henrichsen T; Bjørsvik C; Grotmol T; Saether T; Malm J; Figenschau Y; Rylander L; Levine RJ; Giwercman A
    Clin Endocrinol (Oxf); 2007 Jul; 67(1):85-92. PubMed ID: 17547693
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The frequency of late-onset 21-hydroxylase and 11 beta-hydroxylase deficiency in women with polycystic ovary syndrome.
    Sahin Y; Keleştimur F
    Eur J Endocrinol; 1997 Dec; 137(6):670-4. PubMed ID: 9437235
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical study on 48 cases with complete 17α-hydroxylase deficiency].
    Wang HB; Tian QJ; Sun AJ; Yao FX; Kang XD; Zhang Y; Chen R
    Zhonghua Fu Chan Ke Za Zhi; 2012 Jul; 47(7):518-21. PubMed ID: 23141163
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hormonal evaluation and mutation screening for steroid 21-hydroxylase deficiency in patients with unilateral and bilateral adrenal incidentalomas.
    Patócs A; Tóth M; Barta C; Sasvári-Székely M; Varga I; Szücs N; Jakab C; Gláz E; Rácz K
    Eur J Endocrinol; 2002 Sep; 147(3):349-55. PubMed ID: 12213672
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exhaustive screening of the 21-hydroxylase gene in a population of hyperandrogenic women.
    Blanché H; Vexiau P; Clauin S; Le Gall I; Fiet J; Mornet E; Dausset J; Bellanné-Chantelot C
    Hum Genet; 1997 Nov; 101(1):56-60. PubMed ID: 9385370
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessment of insulin resistance in the idiopathic hirsutism.
    Sarac F; Saygili F; Ozgen G; Tuzun M; Yilmaz C; Kabalak T
    Gynecol Obstet Invest; 2007; 63(3):126-31. PubMed ID: 17057397
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Deficit of 21 beta-hydroxylase. Clinico-functional parameters.
    Gangemi M; Benato M; Guacci AM; Meneghetti G
    Clin Exp Obstet Gynecol; 1983; 10(4):176-81. PubMed ID: 6323056
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Determination of serum steroids in monitoring therapy of congenital adrenal hyperplasia].
    Xiao HW; Ma HM; Su Z; Du ML; Li YH; Chen HS; Chen QL
    Zhonghua Er Ke Za Zhi; 2012 Apr; 50(4):301-7. PubMed ID: 22801236
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Six-month oral dehydroepiandrosterone supplementation in early and late postmenopause.
    Stomati M; Monteleone P; Casarosa E; Quirici B; Puccetti S; Bernardi F; Genazzani AD; Rovati L; Luisi M; Genazzani AR
    Gynecol Endocrinol; 2000 Oct; 14(5):342-63. PubMed ID: 11109974
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of the pituitary-adrenal axis in hyperandrogenic women with polycystic ovary syndrome.
    Luboshitzky R; Ishai A; Shen-Or Z; Herer P
    Neuro Endocrinol Lett; 2003; 24(3-4):249-54. PubMed ID: 14523365
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Variable ACTH-stimulated 17-hydroxyprogesterone values in 21-hydroxylase deficiency carriers are not related to the different CYP21 gene mutations.
    Bachega TA; Brenlha EM; Billerbeck AE; Marcondes JA; Madureira G; Arnhold IJ; Mendonca BB
    J Clin Endocrinol Metab; 2002 Feb; 87(2):786-90. PubMed ID: 11836321
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Urinary 6-sulfatoxymelatonin excretion in hyperandrogenic women with polycystic ovary syndrome: the effect of ethinyl estradiol-cyproterone acetate treatment.
    Luboshitzky R; Shen-Orr Z; Herer P; Nave R
    Gynecol Endocrinol; 2003 Dec; 17(6):441-7. PubMed ID: 14992162
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical and biological phenotypes in late-onset 21-hydroxylase deficiency.
    Dewailly D; Vantyghem-Haudiquet MC; Sainsard C; Buvat J; Cappoen JP; Ardaens K; Racadot A; Lefebvre J; Fossati P
    J Clin Endocrinol Metab; 1986 Aug; 63(2):418-23. PubMed ID: 3013919
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Partial deficiency in 21-hydroxylase in certain forms of hirsutism].
    Lucisano A; Satta MA; Tripodi R; Mobili L; De Cicco F; Monaco F; Dell'Acqua S; Roche J
    C R Seances Soc Biol Fil; 1989; 183(2):117-21. PubMed ID: 2555033
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low serum dehydroepiandrosterone sulfate in women with primary Sjögren's syndrome as an isolated sign of impaired HPA axis function.
    Valtysdóttir ST; Wide L; Hällgren R
    J Rheumatol; 2001 Jun; 28(6):1259-65. PubMed ID: 11409117
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.